南京医药：广药二期基金受让公司11.04%股份过户完成

Core Viewpoint - Alliance Healthcare, a major shareholder of Nanjing Pharmaceutical, has signed a share transfer agreement with Guangzhou Pharmaceutical Phase II Fund to transfer its entire 145 million shares, representing 11.04% of the company, at a price of 5.18 yuan per share, totaling 749 million yuan [1] Group 1 - Alliance Healthcare will no longer hold any shares in Nanjing Pharmaceutical after the transfer [1] - Guangzhou Pharmaceutical Phase II Fund will hold 145 million shares, accounting for 11.04% of the company's total share capital [1] - The share transfer has been confirmed by the China Securities Depository and Clearing Corporation, with the transfer date set for February 26, 2026 [1]